Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology

Changju Qu, Kranthi Kunkalla, Amineh Vaghefi, John K. Frederiksen, Yadong Liu, Jennifer Chapman-Fredricks, Marzenna Blonska, Leon Bernal-Mizrachi, Juan Pablo Alderuccio, Izidore Lossos, Ralf Landgraf, Francisco Vega

Research output: Contribution to journalArticle

Abstract

Tumor necrosis factor receptor-associated factor 6 (TRAF6), an (K63) E3-ligase, plays a role in many biological processes and its activity is relevant in diffuse large B cell lymphoma (DLBCL) biology. Although molecules that trigger TRAF6 activation have been defined, those that stabilize TRAF6 and/or enhance TRAF6 function remain largely unclear. We found that TRAF6 amplifies pAKT signaling in DLBCL. Moreover, TRAF6 activation and stabilization of its ubiquitination profile are facilitated by smoothened (SMO), signal transducer of canonical Hedgehog signaling. Here, we report that SMO is needed to facilitate and maintain TRAF6-dependent elevated pAKT levels, and that the SMO/TRAF6 axis contributes to doxorubicin resistance in DLBCL. Mechanistically, we found that SMO, through its C-terminal tail, stabilizes and protects TRAF6 from degradation, an effect mediated by ubiquitin-specific protease-8. Moreover, this functional link between SMO and TRAF6 is reflected in DLBCL patients where high expression of both molecules correlates with poor prognosis. In summary, our study reveals a novel cell survival mechanism in which SMO stabilizes and protects TRAF6 from degradation. The axis SMO/TRAF6/AKT is highly relevant in the biology of DLBCL and is involved in doxorubicin resistance.

Original languageEnglish (US)
Pages (from-to)149-158
Number of pages10
JournalCancer Letters
Volume436
DOIs
StatePublished - Nov 1 2018

Fingerprint

Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
Lymphoma
Lymphoma, Large B-Cell, Diffuse
Doxorubicin
Ubiquitin-Specific Proteases
Biological Phenomena
Ubiquitin-Protein Ligases
Ubiquitination
Transducers

Keywords

  • Diffuse large B cell lymphoma
  • Hedgehog signaling pathway
  • SMO
  • TRAF6

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Smoothened stabilizes and protects TRAF6 from degradation : A novel non-canonical role of smoothened with implications in lymphoma biology. / Qu, Changju; Kunkalla, Kranthi; Vaghefi, Amineh; Frederiksen, John K.; Liu, Yadong; Chapman-Fredricks, Jennifer; Blonska, Marzenna; Bernal-Mizrachi, Leon; Alderuccio, Juan Pablo; Lossos, Izidore; Landgraf, Ralf; Vega, Francisco.

In: Cancer Letters, Vol. 436, 01.11.2018, p. 149-158.

Research output: Contribution to journalArticle

Qu, Changju ; Kunkalla, Kranthi ; Vaghefi, Amineh ; Frederiksen, John K. ; Liu, Yadong ; Chapman-Fredricks, Jennifer ; Blonska, Marzenna ; Bernal-Mizrachi, Leon ; Alderuccio, Juan Pablo ; Lossos, Izidore ; Landgraf, Ralf ; Vega, Francisco. / Smoothened stabilizes and protects TRAF6 from degradation : A novel non-canonical role of smoothened with implications in lymphoma biology. In: Cancer Letters. 2018 ; Vol. 436. pp. 149-158.
@article{a94adc61091047718adc09d283c27dde,
title = "Smoothened stabilizes and protects TRAF6 from degradation: A novel non-canonical role of smoothened with implications in lymphoma biology",
abstract = "Tumor necrosis factor receptor-associated factor 6 (TRAF6), an (K63) E3-ligase, plays a role in many biological processes and its activity is relevant in diffuse large B cell lymphoma (DLBCL) biology. Although molecules that trigger TRAF6 activation have been defined, those that stabilize TRAF6 and/or enhance TRAF6 function remain largely unclear. We found that TRAF6 amplifies pAKT signaling in DLBCL. Moreover, TRAF6 activation and stabilization of its ubiquitination profile are facilitated by smoothened (SMO), signal transducer of canonical Hedgehog signaling. Here, we report that SMO is needed to facilitate and maintain TRAF6-dependent elevated pAKT levels, and that the SMO/TRAF6 axis contributes to doxorubicin resistance in DLBCL. Mechanistically, we found that SMO, through its C-terminal tail, stabilizes and protects TRAF6 from degradation, an effect mediated by ubiquitin-specific protease-8. Moreover, this functional link between SMO and TRAF6 is reflected in DLBCL patients where high expression of both molecules correlates with poor prognosis. In summary, our study reveals a novel cell survival mechanism in which SMO stabilizes and protects TRAF6 from degradation. The axis SMO/TRAF6/AKT is highly relevant in the biology of DLBCL and is involved in doxorubicin resistance.",
keywords = "Diffuse large B cell lymphoma, Hedgehog signaling pathway, SMO, TRAF6",
author = "Changju Qu and Kranthi Kunkalla and Amineh Vaghefi and Frederiksen, {John K.} and Yadong Liu and Jennifer Chapman-Fredricks and Marzenna Blonska and Leon Bernal-Mizrachi and Alderuccio, {Juan Pablo} and Izidore Lossos and Ralf Landgraf and Francisco Vega",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.canlet.2018.08.020",
language = "English (US)",
volume = "436",
pages = "149--158",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Smoothened stabilizes and protects TRAF6 from degradation

T2 - A novel non-canonical role of smoothened with implications in lymphoma biology

AU - Qu, Changju

AU - Kunkalla, Kranthi

AU - Vaghefi, Amineh

AU - Frederiksen, John K.

AU - Liu, Yadong

AU - Chapman-Fredricks, Jennifer

AU - Blonska, Marzenna

AU - Bernal-Mizrachi, Leon

AU - Alderuccio, Juan Pablo

AU - Lossos, Izidore

AU - Landgraf, Ralf

AU - Vega, Francisco

PY - 2018/11/1

Y1 - 2018/11/1

N2 - Tumor necrosis factor receptor-associated factor 6 (TRAF6), an (K63) E3-ligase, plays a role in many biological processes and its activity is relevant in diffuse large B cell lymphoma (DLBCL) biology. Although molecules that trigger TRAF6 activation have been defined, those that stabilize TRAF6 and/or enhance TRAF6 function remain largely unclear. We found that TRAF6 amplifies pAKT signaling in DLBCL. Moreover, TRAF6 activation and stabilization of its ubiquitination profile are facilitated by smoothened (SMO), signal transducer of canonical Hedgehog signaling. Here, we report that SMO is needed to facilitate and maintain TRAF6-dependent elevated pAKT levels, and that the SMO/TRAF6 axis contributes to doxorubicin resistance in DLBCL. Mechanistically, we found that SMO, through its C-terminal tail, stabilizes and protects TRAF6 from degradation, an effect mediated by ubiquitin-specific protease-8. Moreover, this functional link between SMO and TRAF6 is reflected in DLBCL patients where high expression of both molecules correlates with poor prognosis. In summary, our study reveals a novel cell survival mechanism in which SMO stabilizes and protects TRAF6 from degradation. The axis SMO/TRAF6/AKT is highly relevant in the biology of DLBCL and is involved in doxorubicin resistance.

AB - Tumor necrosis factor receptor-associated factor 6 (TRAF6), an (K63) E3-ligase, plays a role in many biological processes and its activity is relevant in diffuse large B cell lymphoma (DLBCL) biology. Although molecules that trigger TRAF6 activation have been defined, those that stabilize TRAF6 and/or enhance TRAF6 function remain largely unclear. We found that TRAF6 amplifies pAKT signaling in DLBCL. Moreover, TRAF6 activation and stabilization of its ubiquitination profile are facilitated by smoothened (SMO), signal transducer of canonical Hedgehog signaling. Here, we report that SMO is needed to facilitate and maintain TRAF6-dependent elevated pAKT levels, and that the SMO/TRAF6 axis contributes to doxorubicin resistance in DLBCL. Mechanistically, we found that SMO, through its C-terminal tail, stabilizes and protects TRAF6 from degradation, an effect mediated by ubiquitin-specific protease-8. Moreover, this functional link between SMO and TRAF6 is reflected in DLBCL patients where high expression of both molecules correlates with poor prognosis. In summary, our study reveals a novel cell survival mechanism in which SMO stabilizes and protects TRAF6 from degradation. The axis SMO/TRAF6/AKT is highly relevant in the biology of DLBCL and is involved in doxorubicin resistance.

KW - Diffuse large B cell lymphoma

KW - Hedgehog signaling pathway

KW - SMO

KW - TRAF6

UR - http://www.scopus.com/inward/record.url?scp=85052787436&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052787436&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2018.08.020

DO - 10.1016/j.canlet.2018.08.020

M3 - Article

C2 - 30165192

AN - SCOPUS:85052787436

VL - 436

SP - 149

EP - 158

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

ER -